Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solventum (SOLV) Other Non-Current Liabilities (2023 - 2025)

Solventum (SOLV) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $437.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities rose 43.28% year-over-year to $437.0 million, compared with a TTM value of $437.0 million through Sep 2025, up 43.28%, and an annual FY2024 reading of $410.0 million, up 169.74% over the prior year.
  • Other Non-Current Liabilities was $437.0 million for Q3 2025 at Solventum, up from $371.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $437.0 million in Q3 2025 and bottomed at $152.0 million in Q4 2023.
  • Average Other Non-Current Liabilities over 3 years is $303.8 million, with a median of $305.0 million recorded in 2024.
  • The sharpest move saw Other Non-Current Liabilities soared 169.74% in 2024, then increased 21.64% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $152.0 million in 2023, then skyrocketed by 169.74% to $410.0 million in 2024, then rose by 6.59% to $437.0 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for SOLV at $437.0 million in Q3 2025, $371.0 million in Q2 2025, and $279.0 million in Q1 2025.